Roopal Luhana Jul 17, 2018 In December 2017, a federal appeals court reinstated nearly 700 type 2 diabetes medication lawsuits that had previously been dismissed, allowing the cases to move forward because of new evidence that supported the plaintiffs’ claims. The plaintiffs claim that medications like Byetta, Januvia, and Victoza lead to serious injuries, including pancreatic cancer.